Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
deals
hepatitis b
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
2019
activism
acute hepatic porphyria
alexion pharmaceuticals
beijing
bernie sanders
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
brii bio
brii biosciences
bristol-myers squibb
buyout
celgene
charges
china
clinical trials
congress
crisis
detroit blog main
detroit top stories
dicerna pharamceuticals
drug prices
easl
fatty liver disease
fda
givosiran
What
disease
3
×
drug
gene
hepatitis
medicines
adds
advanced
alliance
alnylam’s
approval
areas
bff
bio
biosciences
bio’s
brii
caught
causing
conference
deals
devoted
dicerna
earlier
easl
eye
form
infectious
intended
kicked
launched
liver
major
million
mission
new
pay
pharma
pharmaceuticals
pipeline
producing
Language
unset
Current search:
disease
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
